Fig. 5From: Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trialChange in BMD (%) from baseline in each zone of the ALD group over 2 yearsBack to article page